Beranda › Sindrom Distres Respirasi › South Carolina
Uji klinis Sindrom Distres Respirasi di South Carolina
7 studi untuk Sindrom Distres Respirasi mencari peserta di lokasi di South Carolina.
Kota di South Carolina
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Greenville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- Medical University of South Carolina (MUSC), Charleston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- Medical University of South Carolina (MUSC), Charleston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- Medical University of South Carolina (MUSC), Charleston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- Medical University of South Carolina (MUSC), Charleston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06703073Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- Direct Biologics Investigational Site, Charleston
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT05354141Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
Menerima pesertaStudi observasional
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2025 · NCT06122077Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.